Logo do repositório
 
Publicação

Gold Nanoparticles to Tackle Drug Resistance in Cancer

datacite.subject.fosEngenharia e Tecnologia::Outras Engenharias e Tecnologiaspt_PT
dc.contributor.advisorFernandes, Maria Alexandra
dc.contributor.advisorBaptista, Pedro
dc.contributor.authorPedrosa, Pedro Miguel Pinto Gonçalves Gouveia
dc.date.accessioned2020-01-13T14:52:54Z
dc.date.available2020-01-13T14:52:54Z
dc.date.issued2019
dc.date.submitted2019
dc.description.abstractThe most common type of cancer treatment, chemotherapy, often fails due to the acquisition of resistance. It is therefore of the utmost importance to better understand the cellular mechanisms of resistance, while developing new strategies to tackle drug resistance. Nanomedicine promises to develop new tools for diagnosing and treating of diseases, improving human health. This thesis explored five main strategies to overcome drug resistance in cancer cells: i) new anti-cancer compounds, ii) nanovectorisation and targeting of compounds, iii) gold nanoparticles (AuNP) for hyperthermia and combination with chemotherapy iv) AuNP assisted angiogenesis arrest with laser ablation and chemotherapy v) AuNP mediated gene silencing of efflux pumps. We started by characterizing the mechanism of action of a new anti-tumour compound (ZnD), that was able to reduce the viability of a colon cancer cell line (HCT116 DR) resistant to doxorubicin (DOX), a first-line chemotherapeutic. We vectorized our compound with AuNP, resulting in increased toxicity to HCT116 DR mouse xenografts. Taking advantage of the photothermal properties of AuNP, we combined chemotherapy with photo hyperthermia by irradiating AuNP with a green laser. Hyperthermia was especially effective against HCT116 DR. Since angiogenesis is a milestone in cancer development, we aimed to prevent it, using an anti-angiogenic peptide vectorized with AuNP and laser irradiation, resulting in a vascularization reduction of 91% in vivo. We have observed that ABCB1 efflux pump was the major cause of resistance of DOX resist cell line, therefore we silenced its mRNA with an anti-sense oligonucleotide AuNP. Our results showed that although the silencing was effective, cells did not return to a sensitive phenotype, requiring further experiments. Altogether this thesis shows the potential of nanotechnology for cancer treatment, both in chemotherapy and in surgery, where green lasers are already used. This work can be applied to drug resistant tumours, increasing the efficacy of treatment.pt_PT
dc.identifier.tid101626690
dc.identifier.urihttp://hdl.handle.net/10362/91106
dc.language.isoengpt_PT
dc.relationA DEFINIR
dc.subjectCancerpt_PT
dc.subjectgold nanoparticlespt_PT
dc.subjectNanomedicinept_PT
dc.subjectPhototherapypt_PT
dc.subjectHyperthermiapt_PT
dc.subjectDrug Resistancept_PT
dc.titleGold Nanoparticles to Tackle Drug Resistance in Cancerpt_PT
dc.typedoctoral thesis
dspace.entity.typePublication
oaire.awardNumberPD/BD/105734/2014
oaire.awardTitleA DEFINIR
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/PD%2FBD%2F105734%2F2014/PT
oaire.fundingStreamOE
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typedoctoralThesispt_PT
relation.isProjectOfPublicatione73ace03-3a82-4c12-afb0-e468447a80c0
relation.isProjectOfPublication.latestForDiscoverye73ace03-3a82-4c12-afb0-e468447a80c0
thesis.degree.nameDoutor em Biociências Molecularespt_PT

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Pedrosa_2019.pdf
Tamanho:
6.32 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
348 B
Formato:
Item-specific license agreed upon to submission
Descrição: